Clinomics Inc
KOSDAQ:352770
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinomics Inc
KOSDAQ:352770
|
KR |
|
Frontera Energy Corp
F:3PY3
|
CA |
|
NK Lukoil PAO
OTC:LUKOY
|
RU |
|
CCC Intelligent Solutions Holdings Inc
F:0B1
|
US |
|
Granges AB
F:9GR
|
SE |
|
Kits Eyecare Ltd
F:0P3
|
CA |
|
S
|
Shimano Inc
SWB:SHM
|
JP |
|
B
|
Blackbaud Inc
F:BNK
|
US |
|
Iren SpA
F:TZ8
|
IT |
|
Umicore SA
F:NVJ
|
BE |
|
S
|
SunCoke Energy Inc
SWB:S01
|
US |
|
VGP NV
OTC:VGPBF
|
BE |
|
I
|
Imperial Resources Inc
XPHS:IMP
|
PH |
|
Infinity Metals Ltd
ASX:INF
|
AU |
|
W
|
Wintermar Offshore Marine Tbk PT
F:W6O
|
ID |
|
T
|
Tessenderlo Group NV
F:TEZ
|
BE |
|
S
|
Steppe Cement Ltd
LSE:STCM
|
MY |
|
A
|
Assurant Inc
DUS:ZAS
|
US |
Bankruptcy Probability
Clinomics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Clinomics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Clinomics Inc
KOSDAQ:352770
|
13.4B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
479.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Clinomics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Clinomics Inc has total debt of 2.8B KRW. This includes both short-term (2.5B KRW) and long-term (313.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.